← Leaderboards
Linda L. Demer
University Of California Los Angeles
$9,283,629
Attributed
$13,375,980
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2006–24$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$13,375,980 · 11
By mechanism
R01$10,221,021 · 6
R38$1,066,137 · 1
R21$852,500 · 2
P01$706,274 · 1
T32$530,048 · 1
Top collaborators
- Yin Tintut20 shared
- Olujimi A Ajijola2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Yin Tintut$5,945,406
- Christina Charles-Schoeman$4,000,695
- Jeffrey John Hsu$645,958
- Tamer Sallam$10,795,420
- Aldons Jake Lusis$39,552,334
Others in their field
Top investigators on “Calcification”
- Philip A Wolf · Boston University Medical Campus$22,153,131
- Cecilia M. Giachelli · University Of Washington$20,001,717
- Jose Luis Millan · Burnham Institute For Medical Research$17,909,598
- Alan R. Shuldiner · University Of Maryland Baltimore$17,767,642
- Vasan Ramachandran · Boston University Medical Campus$16,867,030
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$16,601,225
Research focus
CalcificationHyperlipidemiaLinkMorbidity - Disease RateCardiovascular SystemBaseIn VivoSignal TransductionTissuesCytokineCardiovascular DiseasesOsteoporosisBlood VesselsAtherosclerosisArteriesSerumMouse ModelPathway InteractionsReceptorMediatingImagePublic HealthLesionPrevent
Grant awards (37)
Role of intermittent activation of parathyroid hormone receptor in exercise-induced vascular calcification$541,830
R01 · FY2024 · HL · contact PI
Role of intermittent activation of parathyroid hormone receptor in exercise-induced vascular calcification$552,886
R01 · FY2023 · HL · contact PI
The University of California - Los Angeles (UCLA) Resident Scientist Training Program (RSTP)$178,912
R38 · FY2023 · HL
Role of intermittent activation of parathyroid hormone receptor in exercise-induced vascular calcification$552,886
R01 · FY2022 · HL · contact PI
Serotonin receptor contribution to inflammation-induced calcific aortic valve disease$390,000
R01 · FY2022 · HL · contact PI
The University of California - Los Angeles (UCLA) Resident Scientist Training Program (RSTP)$344,757
R38 · FY2022 · HL
Role of intermittent activation of parathyroid hormone receptor in exercise-induced vascular calcification$552,887
R01 · FY2021 · HL · contact PI
Serotonin receptor contribution to inflammation-induced calcific aortic valve disease$390,000
R01 · FY2021 · HL · contact PI
The University of California - Los Angeles (UCLA) Resident Scientist Training Program (RSTP)$344,757
R38 · FY2021 · HL · contact PI
Serotonin receptor contribution to inflammation-induced calcific aortic valve disease$390,000
R01 · FY2020 · HL · contact PI
The University of California - Los Angeles (UCLA) Resident Scientist Training Program (RSTP)$197,711
R38 · FY2020 · HL · contact PI
Does aging transform calcific vasculopathy into a plaque stabilizing process?$195,000
R21 · FY2020 · AG · contact PI
Cardiovascular Scientist Training Program$530,048
T32 · FY2019 · HL · contact PI
Serotonin receptor contribution to inflammation-induced calcific aortic valve disease$390,000
R01 · FY2019 · HL · contact PI
Does aging transform calcific vasculopathy into a plaque stabilizing process?$234,000
R21 · FY2019 · AG · contact PI
Mechanisms of intermittent parathyroid hormone effects on calcific aortic disease$385,000
R01 · FY2018 · HL · contact PI
Mechanisms of intermittent parathyroid hormone effects on calcific aortic disease$385,000
R01 · FY2017 · HL · contact PI
Mechanisms of intermittent parathyroid hormone effects on calcific aortic disease$385,000
R01 · FY2016 · HL · contact PI
Mechanisms of intermittent parathyroid hormone effects on calcific aortic disease$385,000
R01 · FY2015 · HL · contact PI
Role of Inhibitory SMADs in Calcific Aortic Valve Disease$379,225
R01 · FY2015 · HL · contact PI
Role of Inhibitory SMADs in Calcific Aortic Valve Disease$377,300
R01 · FY2014 · HL · contact PI
Role of Inhibitory SMADs in Calcific Aortic Valve Disease$366,520
R01 · FY2013 · HL · contact PI
Role of Inhibitory SMADs in Calcific Aortic Valve Disease$385,000
R01 · FY2012 · HL · contact PI
Role of Lymphatic Clearance in Lipid-Induced Calcific Vasculopathy and Bone Loss$231,000
R21 · FY2012 · HL · contact PI
Role of Lymphatic Clearance in Lipid-Induced Calcific Vasculopathy and Bone Loss$192,500
R21 · FY2011 · HL · contact PI
RANKL/OPG-Mediated Control of Vascular Calcification$375,049
R01 · FY2010 · HL · contact PI
RANKL/OPG-Mediated Control of Vascular Calcification$375,049
R01 · FY2009 · HL · contact PI
RANKL/OPG-Mediated Control of Vascular Calcification$375,049
R01 · FY2008 · HL · contact PI
RANKL/OPG-Mediated Control of Vascular Calcification$375,049
R01 · FY2007 · HL · contact PI
RANKL/OPG-Mediated Control of Vascular Calcification$386,250
R01 · FY2006 · HL · contact PI
Lipid Regulation of Vascular and Bone Osteoclastogenesis$381,250
R01 · FY2004 · HL
Lipid Regulation of Vascular and Bone Osteoclastogenesis$381,250
R01 · FY2003 · HL
Lipid Regulation of Vascular and Bone Osteoclastogenesis$381,250
R01 · FY2002 · HL
MOLECULAR AND CELLULAR MECHANISM OF VASCULAR CALCIFICATION$200,479
P01 · FY2002 · HL
Lipid Regulation of Vascular and Bone Osteoclastogenesis$382,291
R01 · FY2001 · HL
MOLECULAR AND CELLULAR MECHANISM OF VASCULAR CALCIFICATION$200,479
P01 · FY2001 · HL
MOLECULAR AND CELLULAR MECHANISM OF VASCULAR CALCIFICATION$305,316
P01 · FY2000 · HL